Privia Health (PRVA) Common Equity (2020 - 2026)

Privia Health has reported Common Equity for 7 years, with the latest figure at $753.1 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 6.14% year-over-year to $753.1 million; the trailing twelve-month figure through Mar 2026 stood at $753.1 million (up 6.14% YoY), and the FY2025 full-year result was $790.9 million, up 15.73% from the prior year.
• Common Equity for Q1 2026 stood at $753.1 million, down from $790.9 million in the prior quarter.
• The five-year high for Common Equity was $790.9 million in Q4 2025, with the low at $457.9 million in Q1 2022.
• Average Common Equity over 5 years is $624.9 million, with a median of $622.8 million recorded in 2024.
• Year-over-year, Common Equity surged 206.56% in 2022 and climbed 6.14% in 2026.
• Tracing PRVA's Common Equity over 5 years: stood at $519.0 million in 2022, then advanced by 17.02% to $607.4 million in 2023, then grew by 12.52% to $683.4 million in 2024, then grew by 15.73% to $790.9 million in 2025, then dropped by 4.79% to $753.1 million in 2026.
• The last three Common Equity figures came in at $753.1 million (Q1 2026), $790.9 million (Q4 2025), and $762.8 million (Q3 2025), per Business Quant data.

Peer Comparison